Related references
Note: Only part of the references are listed.Key chemokines direct migration of immune cells in solid tumors
Karan Kohli et al.
CANCER GENE THERAPY (2022)
Metabolic heterogeneity of human hepatocellular carcinoma: implications for personalized pharmacological treatment
Nikolaus Berndt et al.
FEBS JOURNAL (2021)
CCR7 as a therapeutic target in Cancer
Anwar Salem et al.
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER (2021)
Role of chemokines in hepatocellular carcinoma
Dongdong Xue et al.
ONCOLOGY REPORTS (2021)
Deciphering Tumor Heterogeneity in Hepatocellular Carcinoma (HCC)-Multi-Omic and Singulomic Approaches
Renumathy Dhanasekaran
SEMINARS IN LIVER DISEASE (2021)
Intratumoural immune heterogeneity as a hallmark of tumour evolution and progression in hepatocellular carcinoma
Phuong H. D. Nguyen et al.
NATURE COMMUNICATIONS (2021)
Hepatocellular carcinoma
Josep M. Llovet et al.
NATURE REVIEWS DISEASE PRIMERS (2021)
Intratumoural immune heterogeneity as a hallmark of tumour evolution and progression in hepatocellular carcinoma (vol 12, 227, 2021)
Phuong H. D. Nguyen et al.
NATURE COMMUNICATIONS (2021)
Chemokines orchestrate tumor cells and the microenvironment to achieve metastatic heterogeneity
Sugandha Saxena et al.
CANCER AND METASTASIS REVIEWS (2021)
Intratumor Heterogeneity in Hepatocellular Carcinoma: Challenges and Opportunities
Sharanya Maanasi Kalasekar et al.
CANCERS (2021)
Advances in immunotherapy for hepatocellular carcinoma
Bruno Sangro et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2021)
Regulation and functional roles of chemokines in liver diseases
Sheng Cao et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2021)
Immunotherapy for Hepatocellular Carcinoma: Current Limits and Prospects
Cheng Zhong et al.
FRONTIERS IN ONCOLOGY (2021)
CXCL2/10/12/14 are prognostic biomarkers and correlated with immune infiltration in hepatocellular carcinoma
Tong Lin et al.
BIOSCIENCE REPORTS (2021)
Cancer stem cells in hepatocellular carcinoma - from origin to clinical implications
Terence Kin-Wah Lee et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2021)
Dissecting spatial heterogeneity and the immune-evasion mechanism of CTCs by single-cell RNA-seq in hepatocellular carcinoma
Yun-Fan Sun et al.
NATURE COMMUNICATIONS (2021)
Tumor Microenvironment Alters Chemoresistance of Hepatocellular Carcinoma Through CYP3A4 Metabolic Activity
Alican Ozkan et al.
FRONTIERS IN ONCOLOGY (2021)
Challenges in liver cancer and possible treatment approaches
David Anwanwan et al.
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER (2020)
Epidemiology and surveillance for hepatocellular carcinoma: New trends
Amit G. Singal et al.
JOURNAL OF HEPATOLOGY (2020)
Immunoactivating the tumor microenvironment enhances immunotherapy as predicted by integrative computational model
Aleksander S. Popel
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)
Intratumoral heterogeneity and clonal evolution in liver cancer
Bojan Losic et al.
NATURE COMMUNICATIONS (2020)
The microenvironmental and metabolic aspects of sorafenib resistance in hepatocellular carcinoma
Shunjie Xia et al.
EBIOMEDICINE (2020)
Chemokines and their Receptors: Multifaceted Roles in Cancer Progression and Potential Value as Cancer Prognostic Markers
Ha Thi Thu Do et al.
CANCERS (2020)
Tumor microenvironment complexity and therapeutic implications at a glance
Roghayyeh Baghba et al.
CELL COMMUNICATION AND SIGNALING (2020)
Relevance of immune cell and tumor microenvironment imaging in the new era of immunotherapy
Filippo Galli et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2020)
Beyond Cell Motility: The Expanding Roles of Chemokines and Their Receptors in Malignancy
Dina Morein et al.
FRONTIERS IN IMMUNOLOGY (2020)
Sorafenib Resistance in Hepatocellular Carcinoma: The Relevance of Genetic Heterogeneity
Loraine Kay D. Cabral et al.
CANCERS (2020)
Intratumoral heterogeneity of hepatocellular carcinoma: From single-cell to population-based studies
Qi Zhang et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2020)
Pro-Inflammatory Cytokines in the Formation of the Pre-Metastatic Niche
Ru Li et al.
CANCERS (2020)
Molecular principles of metastasis: a hallmark of cancer revisited
Jawad Fares et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2020)
Hepatocellular Carcinoma in Hispanic Patients: Trends and Outcomes in a Large United States Cohort
Sydney Pomenti et al.
HEPATOLOGY COMMUNICATIONS (2020)
The cancer matrisome: From comprehensive characterization to biomarker discovery
Alexandra M. Socovich et al.
SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY (2019)
Genomic and transcriptional heterogeneity of multifocal hepatocellular carcinoma
L. X. Xu et al.
ANNALS OF ONCOLOGY (2019)
Integrated multiomic analysis reveals comprehensive tumour heterogeneity and novel immunophenotypic classification in hepatocellular carcinomas
Qi Zhang et al.
GUT (2019)
Tumor-associated macrophages in tumor metastasis: biological roles and clinical therapeutic applications
Yuxin Lin et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2019)
Molecular and histological correlations in liver cancer
Julien Calderaro et al.
JOURNAL OF HEPATOLOGY (2019)
Targeted therapy for hepatocellular carcinoma: Challenges and opportunities
Shuzhen Chen et al.
CANCER LETTERS (2019)
Epidemiology and Management of Hepatocellular Carcinoma
Laura Kulik et al.
GASTROENTEROLOGY (2019)
The Diagnostic Value of Chemokine/Chemokine Receptor Pairs in Hepatocellular Carcinoma and Colorectal Liver Metastasis
Xiaolei Jiao et al.
JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY (2019)
A Dive Into the Deep Heterogeneity of Hepatocellular Carcinoma
Stefano Caruso et al.
GASTROENTEROLOGY (2019)
Tumor-stromal crosstalk in pancreatic cancer and tissue fibrosis
Divya Thomas et al.
MOLECULAR CANCER (2019)
Chromatin accessibility and the regulatory epigenome
Sandy L. Klemm et al.
NATURE REVIEWS GENETICS (2019)
The role of liver microenvironment in hepatic metastasis
Tovah Williamson et al.
CLINICAL AND TRANSLATIONAL MEDICINE (2019)
LI-RADS: a conceptual and historical review from its beginning to its recent integration into AASLD clinical practice guidance
Khaled M. Elsayes et al.
JOURNAL OF HEPATOCELLULAR CARCINOMA (2019)
Chemokines and Chemokine Receptors: New Targets for Cancer Immunotherapy
Valeria Mollica Poeta et al.
FRONTIERS IN IMMUNOLOGY (2019)
LAYN Is a Prognostic Biomarker and Correlated With Immune Infiltrates in Gastric and Colon Cancers
Jing-Hua Pan et al.
FRONTIERS IN IMMUNOLOGY (2019)
The miR-561-5p/CX(3)CL1 Signaling Axis Regulates Pulmonary Metastasis in Hepatocellular Carcinoma Involving CX(3)CR1(+) Natural Killer Cells Infiltration
Er-Bao Chen et al.
THERANOSTICS (2019)
Chemokines: the past, the present and the future
Peng Tang et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2018)
Diagnosis, Staging, and Management of Hepatocellular Carcinoma: 2018 Practice Guidance by the American Association for the Study of Liver Diseases
Jorge A. Marrero et al.
HEPATOLOGY (2018)
Landscape of immune microenvironment in hepatocellular carcinoma and its additional impact on histological and molecular classification
Yutaka Kurebayashi et al.
HEPATOLOGY (2018)
Pembrolizumab in patients with advanced hepatocellular carcinoma previously treated with sorafenib (KEYNOTE-224): a non-randomised, open-label phase 2 trial
Andrew X. Zhu et al.
LANCET ONCOLOGY (2018)
The Role of Desmoplasia and Stromal Fibroblasts on Anti-cancer Drug Resistance in a Microengineered Tumor Model
Harpinder Saini et al.
CELLULAR AND MOLECULAR BIOENGINEERING (2018)
Targeting Chemokines and Chemokine Receptors in Melanoma and Other Cancers
Nicolas Jacquelot et al.
FRONTIERS IN IMMUNOLOGY (2018)
High and low mutational burden tumors versus immunologically hot and cold tumors and response to immune checkpoint inhibitors
Saman Maleki Vareki
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2018)
The significance of intertumor and intratumor heterogeneity in liver cancer
Jinping Liu et al.
EXPERIMENTAL AND MOLECULAR MEDICINE (2018)
Targeting of tumour-infiltrating macrophages via CCL2/CCR2 signalling as a therapeutic strategy against hepatocellular carcinoma
Xiaoguang Li et al.
GUT (2017)
Liver Cancer Cell of Origin, Molecular Class, and Effects on Patient Prognosis
Daniela Sia et al.
GASTROENTEROLOGY (2017)
Incidence of Hepatocellular Carcinoma in All 50 United States, From 2000 Through 2012
Donna L. White et al.
GASTROENTEROLOGY (2017)
Chemokines from a Structural Perspective
Michelle C. Miller et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2017)
Nivolumab in patients with advanced hepatocellular carcinoma (CheckMate 040): an open-label, non-comparative, phase 1/2 dose escalation and expansion trial
Anthony B. El-Khoueiry et al.
LANCET (2017)
Mechanisms of action and regulation of ATP-dependent chromatin-remodelling complexes
Cedric R. Clapier et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2017)
The diagnosis and treatment of hepatocellular carcinoma
Justin Hartke et al.
SEMINARS IN DIAGNOSTIC PATHOLOGY (2017)
Cytokine-Induced Killer Cells As Pharmacological Tools for Cancer Immunotherapy
Xingchun Gao et al.
FRONTIERS IN IMMUNOLOGY (2017)
A Natural CCR2 Antagonist Relieves Tumor-associated Macrophage-mediated Immunosuppression to Produce a Therapeutic Effect for Liver Cancer
Wenbo Yao et al.
EBIOMEDICINE (2017)
Up-regulation of chemokine receptor CCR4 is associated with Human Hepatocellular Carcinoma malignant behavior
Xi Cheng et al.
SCIENTIFIC REPORTS (2017)
TIMER: A Web Server for Comprehensive Analysis of Tumor-Infiltrating Immune Cells
Taiwen Li et al.
CANCER RESEARCH (2017)
Chemokines in the cancer microenvironment and their relevance in cancer immunotherapy
Nisha Nagarsheth et al.
NATURE REVIEWS IMMUNOLOGY (2017)
Tumor microenvironment and therapeutic response
Ting Wu et al.
CANCER LETTERS (2017)
Abstract A90: Combination therapy of chemokine receptor inhibition plus PDL-1 blockade potentiates anti-tumor effects in a murine model of breast cancer
Heiyoun Jung
MOLECULAR CANCER THERAPEUTICS (2016)
Heterogeneity of liver cancer and personalized therapy
Liang Li et al.
CANCER LETTERS (2016)
Chemokines: Chemistry, Biochemistry and Biological Function
Daniel F. Legler et al.
CHIMIA (2016)
Cancer Tills the Premetastatic Field: Mechanistic Basis and Clinical Implications
Andrew R. Chin et al.
CLINICAL CANCER RESEARCH (2016)
Variable Intra-Tumor Genomic Heterogeneity of Multiple Lesions in Patients With Hepatocellular Carcinoma
Ruidong Xue et al.
GASTROENTEROLOGY (2016)
Interfering with epigenetics in hepatocellular carcinoma: Out of the shelter?
Chris Verslype
JOURNAL OF HEPATOLOGY (2016)
Interplay of genetic and epigenetic alterations in hepatocellular carcinoma
Sun-Min Lee et al.
EPIGENOMICS (2016)
Spatial Heterogeneity in the Tumor Microenvironment
Yinyin Yuan
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2016)
Tumor Heterogeneity in Hepatocellular Carcinoma: Facing the Challenges
Li-Chun Lu et al.
LIVER CANCER (2016)
Fundamentals of cancer metabolism
Ralph J. DeBerardinis et al.
SCIENCE ADVANCES (2016)
A guide to immunometabolism for immunologists
Luke A. J. O'Neill et al.
NATURE REVIEWS IMMUNOLOGY (2016)
Intratumor Molecular and Phenotypic Diversity in Hepatocellular Carcinoma
Jean-Charles Nault et al.
CLINICAL CANCER RESEARCH (2015)
Prevalence of Suspected Nonalcoholic Fatty Liver Disease in Hispanic/Latino Individuals Differs by Heritage
Eric R. Kallwitz et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2015)
Temporal Trends of Nonalcoholic Fatty Liver Disease-Related Hepatocellular Carcinoma in the Veteran Affairs Population
Sahil Mittal et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2015)
Smart CARs engineered for cancer immunotherapy
Saul J. Priceman et al.
CURRENT OPINION IN ONCOLOGY (2015)
Metabolic reprogramming: the emerging concept and associated therapeutic strategies
Go J. Yoshida
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2015)
Systematic pan-cancer analysis of tumour purity
Dvir Aran et al.
NATURE COMMUNICATIONS (2015)
Co-expression of CXCL8 and HIF-1α is associated with metastasis and poor prognosis in hepatocellular carcinoma
Xian-Peng Li et al.
ONCOTARGET (2015)
Treatment of Liver Cancer
Chun-Yu Liu et al.
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2015)
Chemokines and their receptors play important roles in the development of hepatocellular carcinoma
Chun-Min Liang et al.
WORLD JOURNAL OF HEPATOLOGY (2015)
BLOCKADE OF THE CXCR6 SIGNALING INHIBITS GROWTH AND INVASION OF HEPATOCELLULAR CARCINOMA CELLS THROUGH INHIBITION OF THE VEGF EXPRESSION
J-M. Xu et al.
INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY (2014)
ELR-CXC chemokine antagonism and cisplatin co-treatment additively reduce H22 hepatoma tumor progression and ameliorate cisplatin-induced nephrotoxicity
Jing Wei et al.
ONCOLOGY REPORTS (2014)
Tumor and the Microenvironment: A Chance to Reframe the Paradigm of Carcinogenesis?
Mariano Bizzarri et al.
BIOMED RESEARCH INTERNATIONAL (2014)
A first-in-human, first-in-class, phase I study of carlumab (CNTO 888), a human monoclonal antibody against CC-chemokine ligand 2 in patients with solid tumors
Shahneen K. Sandhu et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2013)
Histone deacetylase 3 participates in self-renewal of liver cancer stem cells through histone modification
Chungang Liu et al.
CANCER LETTERS (2013)
Targeting Tumor-Infiltrating Macrophages Decreases Tumor-Initiating Cells, Relieves Immunosuppression, and Improves Chemotherapeutic Responses
Jonathan B. Mitchem et al.
CANCER RESEARCH (2013)
CCR1 blockade reduces tumor burden and osteolysis in vivo in a mouse model of myeloma bone disease
Daniel J. Dairaghi et al.
BLOOD (2012)
CXCR6 Upregulation Contributes to a Proinflammatory Tumor Microenvironment That Drives Metastasis and Poor Patient Outcomes in Hepatocellular Carcinoma
Qiang Gao et al.
CANCER RESEARCH (2012)
The Metabolic Profile of Tumors Depends on Both the Responsible Genetic Lesion and Tissue Type
Mariia O. Yuneva et al.
CELL METABOLISM (2012)
Understanding Histone Deacetylases in the Cancer Development and Treatment: An Epigenetic Perspective of Cancer Chemotherapy
Mudassier Ahmad et al.
DNA AND CELL BIOLOGY (2012)
Chemokine-driven lymphocyte infiltration: an early intratumoural event determining long-term survival in resectable hepatocellular carcinoma
Valerie Chew et al.
GUT (2012)
Exome sequencing of hepatitis B virus-associated hepatocellular carcinoma
Jian Huang et al.
NATURE GENETICS (2012)
Integrated analysis of somatic mutations and focal copy-number changes identifies key genes and pathways in hepatocellular carcinoma
Cecile Guichard et al.
NATURE GENETICS (2012)
Linking epithelial-to-mesenchymal-transition and epigenetic modifications
Sonja C. Stadler et al.
SEMINARS IN CANCER BIOLOGY (2012)
The immune contexture in human tumours: impact on clinical outcome
Wolf Herman Fridman et al.
NATURE REVIEWS CANCER (2012)
Hallmarks of Cancer: The Next Generation
Douglas Hanahan et al.
CELL (2011)
Chronic Liver Disease in the Hispanic Population of the United States
Andres F. Carrion et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2011)
Inactivating mutations of the chromatin remodeling gene ARID2 in hepatocellular carcinoma
Meng Li et al.
NATURE GENETICS (2011)
Clinical significance of histone deacetylases 1, 2, 3, and 7: HDAC2 is an independent predictor of survival in HCC
Karl Quint et al.
VIRCHOWS ARCHIV (2011)
How Darwinian models inform therapeutic failure initiated by clonal heterogeneity in cancer medicine
M. Gerlinger et al.
BRITISH JOURNAL OF CANCER (2010)
Inactivation of chemokine (C-C motif) receptor 1 (CCR1) suppresses colon cancer liver metastasis by blocking accumulation of immature myeloid cells in a mouse model
Takanori Kitamura et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Chemokines and chemokine receptors: new insights into cancer-related inflammation
Gwendal Lazennec et al.
TRENDS IN MOLECULAR MEDICINE (2010)
Pretreatment assessment of hepatocellular carcinoma: expert consensus statement
Jean-Nicolas Vauthey et al.
HPB (2010)
Chemokine receptor CXCR4 expression in hepatocellular carcinoma patients increases the risk of bone metastases and poor survival
Zuo-lin Xiang et al.
BMC CANCER (2009)
DNA methylation in hepatocellular carcinoma
Iris Tischoff et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2008)
Mechanistic and prognostic significance of aberrant methylation in the molecular pathogenesis of human hepatocellular carcinoma
Diego F. Calvisi et al.
JOURNAL OF CLINICAL INVESTIGATION (2007)
TP53 mutations and hepatocellular carcinoma:: insights into the etiology and pathogenesis of liver cancer
S. P. Hussain et al.
ONCOGENE (2007)
Transcriptome classification of HCC is related to gene alterations and to new therapeutic targets
Sandrine Boyault et al.
HEPATOLOGY (2007)
Prolonged, NK cell-mediated antitumor effects of suicide gene therapy combined with monocyte chemoattractant protein-1 against hepatocellular carcinoma
Tomoya Tsuchiyama et al.
JOURNAL OF IMMUNOLOGY (2007)
Enhanced expression and clinical significance of CC-chemokine MIP-3α in hepatocellular carcinoma
C. Rubie et al.
SCANDINAVIAN JOURNAL OF IMMUNOLOGY (2006)
The prevalence of hepatitis C virus infection in the United States, 1999 through 2002
Gregory L. Armstrong et al.
ANNALS OF INTERNAL MEDICINE (2006)
Defining the origins and evolution of the chemokine/chemokine receptor system
ME DeVries et al.
JOURNAL OF IMMUNOLOGY (2006)
Hepatocellular carcinoma: Recent trends in the United States
HB El-Serag
GASTROENTEROLOGY (2004)
Share Paper
